Fig. 1From: Level of neo-epitope predecessor and mutation type determine T cell activation of MHC binding peptidesExisting methods and proposed new classifier (a) Current approaches for neo-antigen detection involve three main stages: RNA sequencing, detection of mutations in tumor cells and the computation of MHC binding peptides in such mutated regions. We propose a new stage (b) the detection among the MHC binding peptides of those that manage to induce a T cell responseBack to article page